Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Subscribe To Our Newsletter & Stay Updated